Abstract Background Parkinson's Disease (PD) is a progressive neurodegenerative disorder primarily characterized by motor symptoms such as tremors, rigidity, and bradykinesia. Structural brain changes, including atrophy in the midbrain, basal ganglia, and cortical regions such as the frontal and temporal lobes, are observed in advanced stages.
Suraiya Mangra +5 more
wiley +1 more source
Reviving Hope: Overcoming Deep Brain Stimulation Failure With Partial Cranial Nerve Radiofrequency Ablation in Primary Meige Syndrome. [PDF]
Li X +6 more
europepmc +1 more source
Editorial: Exploring neuromodulation and neuroimaging techniques for psychiatric disorders: insights from preclinical and clinical studies. [PDF]
Sakoglu U, Dietz M, Kallioniemi E.
europepmc +1 more source
Reopening Motor Learning Windows: Targeted Re-Engagement of Latent Pathways via Non-Invasive Neuromodulation. [PDF]
Mac-Auliffe D +2 more
europepmc +1 more source
Voice and Speech in Atypical Parkinsonian Disorders
Background Motor speech disorders are early, common, and functionally limiting features of atypical parkinsonian disorders (APDs) such as progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and multiple system atrophy (MSA). These impairments are underrecognized and undertreated in neurology clinics.
Federico Rodriguez‐Porcel +48 more
wiley +1 more source
Progress in non-invasive neuromodulation based on consciousness-related neural circuits: a narrative review. [PDF]
Wang Y +14 more
europepmc +1 more source
Demonstration of Alpha-Band Entrainment via Low-Field Magnetic Stimulation: A Simulation-Driven Proof of Concept. [PDF]
Dămășaru C +4 more
europepmc +1 more source
Homogenous Cell Transplantation Trials in Parkinson's Disease: A Systematic Review and Meta‐Analysis
Abstract Background The transplantation of homogenous cells has emerged as an investigational strategy for Parkinson's disease (PD), offering an alternative to symptomatic treatment. Objective We performed a systematic review and meta‐analysis to assess its clinical efficacy and safety.
Nolan Reinisch +4 more
wiley +1 more source

